中华消化外科杂志
中華消化外科雜誌
중화소화외과잡지
CHINESE JOURNAL OF DIGESTIVE SURGERY
2013年
5期
352-357
,共6页
王平%陈小伍%方驰华%罗康宁%范应方
王平%陳小伍%方馳華%囉康寧%範應方
왕평%진소오%방치화%라강저%범응방
肝胆管结石病%数字医学%胆道镜探查
肝膽管結石病%數字醫學%膽道鏡探查
간담관결석병%수자의학%담도경탐사
Hepatolithiasis%Digital medicine%Choledochoescopy
目的 探讨医学图像三维可视化系统(MI-3DVS)在经皮肝胆道镜碎石(PTCSL)治疗肝胆管结石病中的临床应用价值.方法 回顾性分析2007年1月至2012年9月两家临床研究中心收治的66例肝胆管结石病患者(南方医科大学附属顺德第一人民医院55例、南方医科大学珠江医院11例)的临床资料.运用MI-3DVS对CT图像进行三维重建,明确结石分布范围、数量、大小、形状等特点,以及与周围肝组织、血管、胆管的关系;术前确定疾病分型,制订PTCSL手术预案,指导施行PTCSL手术,根据术中及术后恢复情况综合评价三维重建可视化技术的应用价值.患者术后采用电话、门诊复查等方式进行随访.结果 采用MI-3DVS成功完成66例患者肝脏、胆道系统、结石、血管三维重建;清晰显示结石的大小、数量、形态、空间位置,胆管狭窄的位置、程度、长度以及周围血管的空间解剖关系.PTCSL手术预案与实际手术的符合率为95.5%(63/66).63例患者手术时间为(117±9)min,术中出血量为(18±1)ml,术后结石清除率为92.4%(61/66),术后并发症发生率为6.1%(4/66),术后住院时间为(15 ±4)d.本组患者随访时间截至2012年9月,中位随访时间为16个月(1~69个月),随访率为100.0%(66/66),术后结石复发率为9.1%(6/66),术后因肿瘤转移并发MODS死亡1例.结论 应用MI-3DVS对肝胆管结石病患者进行诊断和指导PTCSL手术,可有效提高PTCSL手术的安全性和有效性.
目的 探討醫學圖像三維可視化繫統(MI-3DVS)在經皮肝膽道鏡碎石(PTCSL)治療肝膽管結石病中的臨床應用價值.方法 迴顧性分析2007年1月至2012年9月兩傢臨床研究中心收治的66例肝膽管結石病患者(南方醫科大學附屬順德第一人民醫院55例、南方醫科大學珠江醫院11例)的臨床資料.運用MI-3DVS對CT圖像進行三維重建,明確結石分佈範圍、數量、大小、形狀等特點,以及與週圍肝組織、血管、膽管的關繫;術前確定疾病分型,製訂PTCSL手術預案,指導施行PTCSL手術,根據術中及術後恢複情況綜閤評價三維重建可視化技術的應用價值.患者術後採用電話、門診複查等方式進行隨訪.結果 採用MI-3DVS成功完成66例患者肝髒、膽道繫統、結石、血管三維重建;清晰顯示結石的大小、數量、形態、空間位置,膽管狹窄的位置、程度、長度以及週圍血管的空間解剖關繫.PTCSL手術預案與實際手術的符閤率為95.5%(63/66).63例患者手術時間為(117±9)min,術中齣血量為(18±1)ml,術後結石清除率為92.4%(61/66),術後併髮癥髮生率為6.1%(4/66),術後住院時間為(15 ±4)d.本組患者隨訪時間截至2012年9月,中位隨訪時間為16箇月(1~69箇月),隨訪率為100.0%(66/66),術後結石複髮率為9.1%(6/66),術後因腫瘤轉移併髮MODS死亡1例.結論 應用MI-3DVS對肝膽管結石病患者進行診斷和指導PTCSL手術,可有效提高PTCSL手術的安全性和有效性.
목적 탐토의학도상삼유가시화계통(MI-3DVS)재경피간담도경쇄석(PTCSL)치료간담관결석병중적림상응용개치.방법 회고성분석2007년1월지2012년9월량가림상연구중심수치적66례간담관결석병환자(남방의과대학부속순덕제일인민의원55례、남방의과대학주강의원11례)적림상자료.운용MI-3DVS대CT도상진행삼유중건,명학결석분포범위、수량、대소、형상등특점,이급여주위간조직、혈관、담관적관계;술전학정질병분형,제정PTCSL수술예안,지도시행PTCSL수술,근거술중급술후회복정황종합평개삼유중건가시화기술적응용개치.환자술후채용전화、문진복사등방식진행수방.결과 채용MI-3DVS성공완성66례환자간장、담도계통、결석、혈관삼유중건;청석현시결석적대소、수량、형태、공간위치,담관협착적위치、정도、장도이급주위혈관적공간해부관계.PTCSL수술예안여실제수술적부합솔위95.5%(63/66).63례환자수술시간위(117±9)min,술중출혈량위(18±1)ml,술후결석청제솔위92.4%(61/66),술후병발증발생솔위6.1%(4/66),술후주원시간위(15 ±4)d.본조환자수방시간절지2012년9월,중위수방시간위16개월(1~69개월),수방솔위100.0%(66/66),술후결석복발솔위9.1%(6/66),술후인종류전이병발MODS사망1례.결론 응용MI-3DVS대간담관결석병환자진행진단화지도PTCSL수술,가유효제고PTCSL수술적안전성화유효성.
Objective To investigate the clinical value of medical image-three dimensional visible system (MI-3DVS) in percutaneous transhepatic cholangioscopy lithotripsy (PTCSL) for the treatment of hepatolithiasis.Methods The clinical data of 66 patients with hepatolithiasis (55 were from the First People's Hospital of Shunde City and 11 were from the Zhujiang Hospital) were retrospectively analyzed.The images of computed tomography were three-dimensionally reconstructed with MI-3DVS.The location,number,size,shape of the stones were figured out,and the operation strategies of PTCSL were designed according to the types of the disease.The clinical value of MI-3DVS was evaluated according to the operation results and postoperative recovery of patients.All the patients were followed up via telephone or out-patient re-examination.Results Liver,biliary system,stones and blood vessels were three-dimensionally reconstructed with the MI-3 DVS,and the size,number,shape,location of the stones and location,degree,length of the biliary stricture and its anatomical relationship with adjacent blood vessels were clearly displayed.The coincidence rate of planned and actual operations was 95.5% (63/66).The mean operation time,intraoperative blood loss,rate of stone clearance,complication rate and duration of hospital stay of 63 patients were (117 ± 9) minutes,(18 ± 1) ml,92.4% (61/66),6.1% (4/66) and (15 ± 4) days,respectively.All the patients were followed up till September 2012,the median survival time was 16 months (range,1-69 months),and the recurrence rate of hepatolithiasis was 9.1% (6/66).One patient died of tumor metastasis and multi-organ dysfunction syndrome postoperatively.Conclusion MI-3DVS could effectively improve the safety and efficiency of PTCSL for patients with hepatolithiasis.